Dr Ravi Kumar Dandamudi, Consultant Clinical Oncologist
Dr Ravi Kumar Dandamudi
Consultant Clinical Oncologist
Dr Ravi Kumar Dandamudi Dip BSLM/IBLM, MBBS, MRCP(UK), FRCR
Consultant Clinical Oncologist
Dr Ravi Kumar Dandamudi
Consultant Clinical Oncologist Dip BSLM/IBLM, MBBS, MRCP(UK), FRCR
About Dr Ravi Kumar Dandamudi
GMC number: 5196853
Year qualified: 1996
Place of primary qualification: University of Health Sciences
Dr Ravi K Dandamudi is a Consultant Clinical Oncologist based in Wolverhampton, providing both NHS and private oncology care. He has been serving as a Consultant Oncologist at the Royal Wolverhampton Hospitals NHS Trust since 2015. In private practice, he consults at GenesisCare Birmingham and Nuffield Health Wolverhampton Hospital.
He graduated in 1996 and completed his higher specialist oncology training in the West Midlands. He specialises in the treatment of bladder, prostate, breast, and gynaecological cancers, offering a full range of modern treatment options tailored to each patient.
Dr Dandamudi is highly experienced in delivering advanced radiotherapy techniques, including intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), and adaptive radiotherapy, particularly for prostate cancer. He is also skilled in gynaecological brachytherapy.
In addition to radiotherapy, he offers chemotherapy and immunotherapy for bladder cancer. He maintains a strong interest in clinical research, particularly in the development of new treatment strategies for bladder cancer. His approach combines evidence-based care with the latest innovations in cancer therapy.
Areas of expertise
- Bladder cancer
- Brachytherapy
- Brain metastasis
- Breast cancer
- Cancer prevention and screening
- Chemotherapy
- Clinical trials
- Gynaecological cancers
- Hormone therapy
- Image guided radiotherapy (IGRT)
- Immunotherapy
- Intensity modulated radiotherapy (IMRT)
- Neoadjuvant
- Ovarian cancer
- Prostate cancer
- Radiotherapy
- Renal (kidney) cancer
- Stereotactic ablative radiotherapy (SABR)
- Targeted therapy
- Urological cancers
Professional memberships